67 related articles for article (PubMed ID: 18722320)
1. Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?
Melendo-Viu M; Dobarro D; Marchán López Á; Domínguez LM; Raposeiras-Roubín S; Abu-Assi E; Cardero-González C; Pérez-Expósito L; Cespón Fernández M; Parada Barcia JA; Barreiro Pérez M; García E; Íñiguez Romo A
Int J Cardiol; 2023 Sep; 386():59-64. PubMed ID: 37169152
[TBL] [Abstract][Full Text] [Related]
2. Advantage of uptitration of foundational heart failure drugs in heart failure with reduced ejection fraction and low blood pressure.
Hullin R
Eur J Heart Fail; 2024 Feb; 26(2):370-372. PubMed ID: 38269645
[No Abstract] [Full Text] [Related]
3. How Do I Optimize Heart Failure Medications for Patients with Hypotension or Chronic Kidney Disease?
Gilstrap LG; Vest AR
NEJM Evid; 2022 Oct; 1(10):EVIDccon2200084. PubMed ID: 38319838
[TBL] [Abstract][Full Text] [Related]
4. Sex Differences in CardioMEMS Utilization and Impact on Readmissions and Mortality in Heart Failure Patients.
Markson F; Abe TA; Adedinsewo D; Olanipekun T; Shamaki GR; Kesiena O; Mentz RJ; Michos ED
JACC Heart Fail; 2023 Dec; 11(12):1760-1762. PubMed ID: 37855756
[No Abstract] [Full Text] [Related]
5. Prevalence of office and ambulatory hypotension in treated hypertensive patients with coronary disease.
Divisón-Garrote JA; de la Cruz JJ; de la Sierra A; Vinyoles E; Gorostidi M; Escobar-Cervantes C; Segura J; Barrios V; Ruilope LM; Banegas JR
Hypertens Res; 2020 Jul; 43(7):696-704. PubMed ID: 32398795
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial.
Pitt B; Kober L; Ponikowski P; Gheorghiade M; Filippatos G; Krum H; Nowack C; Kolkhof P; Kim SY; Zannad F
Eur Heart J; 2013 Aug; 34(31):2453-63. PubMed ID: 23713082
[TBL] [Abstract][Full Text] [Related]
7. Ambulatory blood pressure improves prediction of cardiovascular risk: implications for better antihypertensive management.
Krakoff LR
Curr Atheroscler Rep; 2013 Apr; 15(4):317. PubMed ID: 23423525
[TBL] [Abstract][Full Text] [Related]
8. Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial).
Desai RV; Banach M; Ahmed MI; Mujib M; Aban I; Love TE; White M; Fonarow G; Deedwania P; Aronow WS; Ahmed A
Am J Cardiol; 2010 Jul; 106(2):221-7. PubMed ID: 20599007
[TBL] [Abstract][Full Text] [Related]
9. Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: how much is too much?
Pitt B
Curr Heart Fail Rep; 2009 Jun; 6(2):112-6. PubMed ID: 19486595
[TBL] [Abstract][Full Text] [Related]
10. A hard look at angiotensin receptor blockers in heart failure.
Gring CN; Francis GS
J Am Coll Cardiol; 2004 Nov; 44(9):1841-6. PubMed ID: 15519017
[TBL] [Abstract][Full Text] [Related]
11. Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.
Gradman AH; Papademetriou V
Am Heart J; 2009 Jun; 157(6 Suppl):S17-23. PubMed ID: 19450720
[TBL] [Abstract][Full Text] [Related]
12. Multiple neurohumoral modulating agents in systolic dysfunction heart failure: are we lowering blood pressure too much?
Mak G; Murphy NF; Ali A; Walsh A; O'Loughlin C; Conlon C; McCaffrey D; Ledwidge M; McDonald K
J Card Fail; 2008 Sep; 14(7):555-60. PubMed ID: 18722320
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
Thanikachalam S; Manchanda SC
Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
[TBL] [Abstract][Full Text] [Related]
14. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
[TBL] [Abstract][Full Text] [Related]
15. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
